More from ETFs
Not all the news from the small biotech space is bad. One company in particular already has been gaining the attention of investors.
Volatility is picking up, but I believe it could become much more intense in the first half of next year.
If I've got money in the homebuilders, I'm looking to sell a bounce, not buy one.
As the iShares Russell 2000 ETF almost returns to where it started the year, our attention turns to the Invesco QQQ Trust.
Homebuilders and owners of commercial real estate in particular are feeling the rate-induced pain, and it likely will intensify in the months ahead.